Department of Pathology, Cytopathology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey.
Cancer Cytopathol. 2020 Jun;128(6):392-402. doi: 10.1002/cncy.22271. Epub 2020 Apr 8.
Fine needle aspiration (FNA) is commonly used for the preoperative evaluation of salivary gland tumors. Tumor grade is a key factor influencing clinical management of salivary gland carcinomas (SGCs). To assess the ability to grade nonbasaloid SGCs in FNA specimens, an international panel of cytopathologists convened to review and score SGC cases.
The study cohort included 61 cases of primary SGC from the pathology archives of 3 tertiary medical centers. Cases from 2005 to 2016 were selected, scanned, and digitized. Nineteen cytopathologists blinded to the histologic diagnosis reviewed the digitized cytology slides and graded them as low, high, or indeterminate. The panelists' results were then compared to the tumor grades based on histopathologic examination of the corresponding resection specimens.
All but 2 of the 19 (89.5%) expert panelists review more than 20 salivary gland FNAs per year; 16 (84.2%) of the panelists work at academic medical centers, and 13 (68.4%) have more than 10 years' experience. Participants had an overall accuracy of 89.4% in the grading of SGC cases, with 90.2% and 88.3% for low- and high-grade SGC, respectively. Acinic cell carcinoma and mucoepidermoid carcinoma had the highest degree of accuracy, while epithelial-myoepithelial carcinoma and salivary duct carcinoma had the lowest degree of accuracy. As expected, the intermediate-grade SGC cases showed the greatest variability (high-grade, 42.1%; low-grade, 37.5%, indeterminate, 20.4%).
This study confirms the high accuracy of cytomorphologic grading of primary SGC by FNA as low- or high-grade. However, caution should be exercised when a grade cannot be confidently assigned.
细针抽吸(FNA)常用于唾液腺肿瘤的术前评估。肿瘤分级是影响唾液腺癌(SGC)临床管理的关键因素。为了评估在 FNA 标本中对非基底细胞样 SGC 进行分级的能力,一个国际细胞病理学家小组聚集在一起审查和评分 SGC 病例。
该研究队列包括来自 3 个三级医疗中心病理档案的 61 例原发性 SGC。选择了 2005 年至 2016 年的病例,进行扫描和数字化。19 名对组织学诊断不知情的细胞病理学家审查了数字化的细胞学幻灯片,并将其评为低、高或不确定。然后将小组成员的结果与相应切除标本的组织病理学检查的肿瘤分级进行比较。
除了 2 例(89.5%)外,所有 19 名专家小组成员每年审查超过 20 例唾液腺 FNA;16 名(84.2%)小组成员在学术医疗中心工作,13 名(68.4%)具有 10 年以上经验。参与者对 SGC 病例的分级总体准确率为 89.4%,低级别和高级别分别为 90.2%和 88.3%。腺泡细胞癌和黏液表皮样癌的准确率最高,而上皮-肌上皮癌和唾液导管癌的准确率最低。正如预期的那样,中级 SGC 病例的变异性最大(高级别,42.1%;低级别,37.5%,不确定,20.4%)。
这项研究证实了通过 FNA 对原发性 SGC 进行低级别或高级别细胞形态学分级的高度准确性。然而,当不能自信地分配等级时,应谨慎行事。